NCT01448954View on ClinicalTrials.gov

A Study to Evaluate Safety, Tolerability and Pharmacokinetics of ADC3680B in Subjects With Partly Controlled Atopic Asthma

PHASE2CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

February 29, 2012

Study Completion Date

February 29, 2012

Conditions
Atopic Asthma
Interventions
DRUG

ADC3680B oral

Once daily for 28 days

DRUG

Placebo oral

Once daily for 28 days

Trial Locations (2)

BT9 6AD

Belfast

M23 9QZ

Manchester

Sponsors
All Listed Sponsors
lead

Pulmagen Therapeutics

INDUSTRY